Ivermectic tablets found to contain undeclared substances

A study by the Soweto Clinical Trial Centre has shown that 80-percent of Ivermectic tablets found in South Africa contain at least one undeclared substance. According to the centre's Managing Director, Dr Qasim Ebrahim Bhorat, the ingredients could have dangerous consequences for patients. The health products regulator, SAHPRA, recently approved the compassionate use of Ivermectin for the treatment of COVID-19 but under strict conditions. Health practitioners have been allowed to prescribe the drug under Section 21 authorisation of the Medicines and Related Substances Act, even though the drug isn't registered for human use in the country. Prabashini Moodley reports...